Preloaded Combination Nicotine Replacement Therapy on Smoking Cessation of Adult Population in Kazakhstan
Effectiveness of Preloaded Combination Nicotine Replacement Therapy on Smoking Cessation of Adult Population in Kazakhstan- A Randomized Controlled Trial
Sponsor: Astana Medical University
A EARLY_PHASE1 clinical study on Smoking Behaviors and Smoking Cessation, this trial is ongoing. The trial is conducted by Astana Medical University and has accumulated 5 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
5 versions recorded-
Apr 2025 — Present [monthly]
Unknown EARLY_PHASE1
Status: Not Yet Recruiting → Unknown
-
Sep 2024 — Apr 2025 [monthly]
Not Yet Recruiting EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting EARLY_PHASE1
-
Apr 2023 — Jul 2024 [monthly]
Not Yet Recruiting EARLY_PHASE1
-
Sep 2022 — Apr 2023 [monthly]
Not Yet Recruiting EARLY_PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Astana Medical University
- Nazarbayev University
For direct contact, visit the study record on ClinicalTrials.gov .